BMT CTN Protocol 1301 (PROGRESS II)

A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions
for Prevention of Graft-versus Host-Disease.

Below are protocol-related documents, which may be periodically updated.

            Protocol Co-Chair: Leo Luznik, MD

            Protocol Co-Chair: Miguel-Angel Perales, MD (212-639-8682)

            Protocol Co-Chair: Marcelo Pasquini, MD (414-805-0700)

            Protocol Coordinator: Kristy Applegate (301-251-1161)

            Medical Monitor: Tamila Kindwall-Keller, MD (434-982-6406)

The BMT CTN is committed to including widespread transplant community participation in these trials. However, due to the limited resources, not all requests can be accommodated for each protocol. If your center is interested in participating, please fax the completed Affiliate Center Application, or you may complete the short form if currently participating as an affiliate center in any other BMT CTN trial, fax to BMT CTN DCC/Emmes at 240-306-0963.